東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/08/15 | 3,000 | 3,020 | 2,977 | 2,990 | +13 | +0.4% | 199,100 |
2025/08/14 | 3,030 | 3,040 | 2,958 | 2,977 | -33 | -1.1% | 253,600 |
2025/08/13 | 2,965 | 3,010 | 2,935 | 3,010 | +62 | +2.1% | 311,500 |
2025/08/12 | 2,977 | 2,980 | 2,925 | 2,948 | +2 | +0.1% | 357,700 |
2025/08/08 | 2,981 | 2,997 | 2,908 | 2,946 | -384 | -11.5% | 720,500 |
2025/08/07 | 3,365 | 3,365 | 3,285 | 3,330 | -85 | -2.5% | 128,500 |
2025/08/06 | 3,385 | 3,415 | 3,370 | 3,415 | +45 | +1.3% | 82,800 |
2025/08/05 | 3,355 | 3,370 | 3,320 | 3,370 | +30 | +0.9% | 59,800 |
2025/08/04 | 3,330 | 3,385 | 3,320 | 3,340 | -25 | -0.7% | 90,700 |
2025/08/01 | 3,325 | 3,395 | 3,280 | 3,365 | +65 | +2% | 143,800 |
2025/07/31 | 3,270 | 3,325 | 3,270 | 3,300 | +30 | +0.9% | 124,700 |
2025/07/30 | 3,240 | 3,270 | 3,230 | 3,270 | +25 | +0.8% | 90,800 |
2025/07/29 | 3,210 | 3,260 | 3,185 | 3,245 | +30 | +0.9% | 74,400 |
2025/07/28 | 3,200 | 3,230 | 3,190 | 3,215 | -5 | -0.2% | 51,700 |
2025/07/25 | 3,225 | 3,255 | 3,200 | 3,220 | +20 | +0.6% | 94,300 |
2025/07/24 | 3,225 | 3,225 | 3,190 | 3,200 | -15 | -0.5% | 68,900 |
2025/07/23 | 3,230 | 3,240 | 3,195 | 3,215 | +20 | +0.6% | 98,700 |
2025/07/22 | 3,205 | 3,230 | 3,185 | 3,195 | -10 | -0.3% | 56,100 |
2025/07/18 | 3,200 | 3,230 | 3,180 | 3,205 | +5 | +0.2% | 99,900 |
2025/07/17 | 3,170 | 3,215 | 3,145 | 3,200 | +45 | +1.4% | 92,800 |
2025/07/16 | 3,150 | 3,175 | 3,145 | 3,155 | -15 | -0.5% | 78,600 |
2025/07/15 | 3,135 | 3,170 | 3,115 | 3,170 | +20 | +0.6% | 80,200 |
2025/07/14 | 3,055 | 3,165 | 3,055 | 3,150 | +100 | +3.3% | 146,700 |
2025/07/11 | 3,045 | 3,130 | 3,030 | 3,050 | +20 | +0.7% | 132,800 |
2025/07/10 | 3,010 | 3,030 | 3,000 | 3,030 | +20 | +0.7% | 130,400 |
2025/07/09 | 2,989 | 3,020 | 2,958 | 3,010 | +53 | +1.8% | 153,900 |
2025/07/08 | 2,968 | 2,970 | 2,931 | 2,957 | -19 | -0.6% | 130,600 |
2025/07/07 | 2,984 | 3,010 | 2,953 | 2,976 | +42 | +1.4% | 135,600 |
2025/07/04 | 2,941 | 2,958 | 2,925 | 2,934 | -16 | -0.5% | 72,200 |
2025/07/03 | 2,980 | 2,982 | 2,925 | 2,950 | -28 | -0.9% | 115,800 |
2025/07/02 | 2,947 | 2,993 | 2,931 | 2,978 | -19 | -0.6% | 275,800 |
2025/07/01 | 3,015 | 3,045 | 2,979 | 2,997 | +6 | +0.2% | 118,800 |
2025/06/30 | 2,979 | 3,015 | 2,979 | 2,991 | -2 | -0.1% | 106,300 |
2025/06/27 | 2,978 | 3,000 | 2,963 | 2,993 | -4 | -0.1% | 112,900 |
2025/06/26 | 2,980 | 2,997 | 2,948 | 2,997 | -8 | -0.3% | 131,000 |
2025/06/25 | 2,976 | 3,040 | 2,971 | 3,005 | +63 | +2.1% | 173,600 |
2025/06/24 | 2,957 | 2,967 | 2,910 | 2,942 | +25 | +0.9% | 131,500 |
2025/06/23 | 2,930 | 2,941 | 2,905 | 2,917 | -36 | -1.2% | 141,400 |
2025/06/20 | 2,956 | 2,970 | 2,931 | 2,953 | -3 | -0.1% | 233,000 |
2025/06/19 | 2,999 | 2,999 | 2,941 | 2,956 | -43 | -1.4% | 100,700 |
2025/06/18 | 2,967 | 3,015 | 2,965 | 2,999 | +10 | +0.3% | 123,600 |
2025/06/17 | 2,966 | 3,005 | 2,947 | 2,989 | -3 | -0.1% | 134,000 |
2025/06/16 | 2,955 | 3,015 | 2,924 | 2,992 | +33 | +1.1% | 113,100 |
2025/06/13 | 3,015 | 3,025 | 2,956 | 2,959 | -76 | -2.5% | 128,100 |
2025/06/12 | 3,025 | 3,060 | 3,005 | 3,035 | +15 | +0.5% | 92,600 |
2025/06/11 | 3,060 | 3,075 | 3,020 | 3,020 | -30 | -1% | 86,100 |
2025/06/10 | 3,100 | 3,115 | 3,030 | 3,050 | -50 | -1.6% | 89,300 |
2025/06/09 | 3,155 | 3,155 | 3,085 | 3,100 | -25 | -0.8% | 97,700 |
2025/06/06 | 3,200 | 3,210 | 3,120 | 3,125 | -65 | -2% | 75,500 |
2025/06/05 | 3,220 | 3,240 | 3,190 | 3,190 | -25 | -0.8% | 104,700 |
1~
50
件表示中 / 7016件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 299,000円 | +7.9% | -3.3% | 2.68% | 8.32倍 | 0.86倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
科研薬 | 386,000円 | -6.4% | -71.8% | 4.92% | 42.99倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
ジーエヌアイ | 298,300円 | +21.7% | +999.9% | 0.00% | 13.74倍 | 4.70倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 313,500円 | +5.1% | -7.0% | 2.55% | 20.58倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ゼリア新薬 | 202,100円 | +3.1% | -6.5% | 2.38% | 9.38倍 | 0.99倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム